Evidence: well sourced. Imported from the supplied 65-Case Master Edition, dated September 19, 2026. Source links and classifications are retained as an attributed case account; import is not an independent source review.

Case at a glance

Case number
054
Date / range
2011–2012
Sector
Pathogen and research-data governance
Genetic asset
Dual-use pathogen research information
Security principle
Information Hazard Governance

Event summary

The 2011–2012 H5N1 transmissibility controversy forced researchers, journals, and governments to decide whether experimental methods and mutations should be fully published when the same information might support preparedness or misuse.

Source: osp.od.nih.gov — H5N1 Transmissibility Research And Publication source 1.

Source: nih.gov — H5N1 Transmissibility Research And Publication source 2.

The case in context

The H5N1 debate placed scientific access and misuse concerns in direct tension. The policy question was how to assess disclosure of research information that could support legitimate preparedness while also presenting risks.

This account stays at the governance level. It does not reproduce experimental procedures, mutations, or instructions. The lesson concerns review responsibilities, the scope of disclosure, and coordination between researchers, publishers, and authorities. Neither publication nor redaction can be treated as proof that all biosafety and security questions have been resolved.

Acquisition and processing

pathogen manipulation → genomic/experimental findings → dual-use review → proposed redaction → global debate → publication and policy change

The sequence of events

  1. pathogen manipulation
  2. genomic/experimental findings
  3. dual-use review
  4. proposed redaction
  5. global debate
  6. publication and policy change

What became inferable or exposed

Dual-use pathogen research information

The 2011–2012 H5N1 transmissibility controversy forced researchers, journals, and governments to decide whether experimental methods and mutations should be fully published when the same information might support preparedness or misuse.

Security dimensions

Confidentiality

The confidentiality question concerns dual-use pathogen research information. Exposure and further inference must be distinguished from the fact of collection or availability.

Integrity

The integrity question is whether the described material, permissions, processing, or interpretation can be relied upon. Information Hazard Governance identifies the particular boundary examined here.

Availability

Access and continuity are assessed for the described event; potential effects are not presented as confirmed outages or losses.

Provenance

The relevant chain follows dual-use pathogen research information through the stages shown below. Missing public detail is not proof that internal records did not exist.

GeneticSecurity.org analysis

Genetic Exposure Radius

Not assessed

No single level is assigned where the supplied dossier gives a range, conditional outcome, or broad institutional consequence. The affected parties and proposed assessment are shown separately.

Confidence: not assigned. Classification: GeneticSecurity.org analysis.

Genetic Persistence Risk

Not assessed

Persistence depends on the specific biological material or information retained. A potential effect is not treated as an observed genomic disclosure.

Confidence: not assigned. Classification: GeneticSecurity.org analysis.

Genetic Provenance Integrity

Not assessed

A numeric provenance level is not inferred from the existence of a source or court record. It requires evidence of the relevant custody and processing controls.

Confidence: not assigned. Classification: GeneticSecurity.org analysis.

Proposed classification and its limits

Suggested GER: GER-5. GPR: use a pathogen-information persistence note, not the human scale. Suggested GPI: GPI-4 for peer-reviewed methods with documented custody.

These are proposed classifications from the supplied case dossier. Conditional scores describe an assumed exposure; they are not evidence that it occurred. A single numeric value is left unassigned when the asset or outcome is not sufficiently bounded.

What this case does not prove

It does not establish that publication caused misuse or that secrecy would have eliminated biosafety risk.

Mitigations and lessons

  • Durable dual-use review
  • Staged disclosure
  • Biosafety verification
  • Need-to-know technical annexes where justified
  • International coordination
  • Periodic policy review

Primary sources

Secondary sources

No additional source listed. See the evidence notes for limitations.

Policy and standards

Genetic Security Policy and Standards

Review and correction history

Source edition: September 19, 2026. Imported case account; no substantive corrections recorded.

Correction policy and log

Cite this case

GS-CASE-054. The H5N1 Publication Fight: When Genomic Detail Became Dual-Use Information. GeneticSecurity.org. https://geneticsecurity.org/cases/054-h5n1-dual-use-genome-publication/